公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2012 | A phase I/II study of foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2, and VEGFR in advanced hepatocellular carcinoma (HCC). | Yau, Thomas Cheung; Sukeepaisarnjaroen, Wattana; Chao, Yee; Yen, Chia-Jui; Lausoontornsiri, Wirote; Chen, Pei-Jer; Sanpajit, Theeranun; Lencioni, Riccardo; Camp, Aaron C.; Cox, Donna S.; Kallender, Howard; Ottesen, Lone Harild; Poon, Ronnie Tung-Ping | J. Clin. Oncol. | | | |
2024 | Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08) | Wang, Hung-Ming; PEI-JEN LOU ; Yang, Muh-Hwa; Chen, Tein-Hua; Lien, Ming-Yu; Lin, Jin-Ching; JO-PAI CHEN ; Lu, Wei-Chen; Lu, Hsueh-Ju; Huang, Tai-Lin; Yen, Chia-Jui; Wu, Shang-Yin; Wang, Hui-Ching; Hsieh, Meng-Che | Targeted oncology | | | |
2024 | Clinical outcomes of cetuximab-based treatment for distant metastatic head and neck squamous cell carcinoma: A real-world study using Taiwan Head Neck Society registry database | Lu, Hsueh-Ju; Hsieh, Meng-Che; Wang, Hung-Ming; Hsieh, Jason Chia-Hsun; Yen, Chia-Jui; Wu, Shang-Yin; Huang, Huai-Cheng; Wang, Hui-Ching; Chu, Pen-Yuan; Chen, Tien-Hua; Chien, Chih-Yen; Huang, Tai-Lin; Chang, Yi-Fang; Hua, Chun-Hung; Lien, Ming-Yu; Chen, Jo-Pai; Lu, Wei-Chen; Lin, Jin-Ching; Wang, Chen-Chi; Liu, Yi-Chun; Yang, Muh-Hwa; PEI-JEN LOU | Head & neck | | | |
2024 | Clinical practice consensus for the diagnosis and management of melanoma in Taiwan | Wu, Chiao-En; YI-HUA LIAO ; Wu, Cheng-Lin; RUOH-FANG YEN ; CHIA-CHI LIN ; Yang, Muh-Hwa; Yen, Chueh-Chuan; Su, Wu-Chou; Yen, Chia-Jui; Chang, Yi-Fang; Wu, Ming-Fang; Yang, Youngsen; Lin, Chen-Yuan; Yang, Wen-Chi; Wang, Hui-Ching; Li, Cheng-Yuan; Ho, Yin-Yu; Chang, Yao-Yu; Wu, Chieh-Shan; Hsu, Hsiu-Cheng; Chen, Kuang-Hua; Huang, Yenlin; Chen, Chih-Jung; Chuang, Pei-Ju; Lai, Yung-Chi; Huang, Yu-Yi; Tseng, Neng-Chuan; Huang, Yi-Ting; CHIA-YU CHU ; Wen-Cheng Chang, John | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 0 | |
2023 | Combination of GT90001 and nivolumab in patients with advanced hepatocellular carcinoma: a multicenter, single-arm, phase 1b/2 study | CHIUN HSU ; Chang, Yi-Fang; Yen, Chia-Jui; Xu, Yu-Wei; Dong, Min; Tong, You-Zhi | BMC medicine | 1 | | |
2022 | Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study | Su, Yung-Yeh; Chiang, Nai-Jung; Li, Chung-Pin; Yen, Chia-Jui; SHIH-HUNG YANG ; Chou, Wen-Chi; Chen, Jen-Shi; Chiu, Tai-Jan; Chen, Yen-Yang; Chuang, Shih-Chang; Bai, Li-Yuan; Chiu, Chang-Fang; Peng, Cheng-Ming; Chan, De-Chuan; Chiu, Sz-Chi; Yang, Yi-Hsin; Shan, Yan-Shen; Chen, Li-Tzong | Frontiers in oncology | 3 | 3 | |
2022 | Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin | Chiu, Tai-Jan; SHIH-HUNG YANG ; Chiu, Sz-Chi; Hsueh, Shun-Wen; Chiang, Nai-Jung; Li, Chung-Pin; Bai, Li-Yuan; Cheng, Fu-Ming; Chuang, Shih-Chang; Shan, Yan-Shen; Chan, De-Chuan; Chen, Li-Tzong; Yen, Chia-Jui; Peng, Cheng-Ming; Su, Yung-Yeh; Chen, Yen-Yang; Chen, Jen-Shi; Chou, Wen-Chi | Journal of hepato-biliary-pancreatic sciences | 2 | 2 | |
2021 | Effects of Exercise in Patients Undergoing Chemotherapy for Head and Neck Cancer: A Pilot Randomized Controlled Trial | KUAN-YIN LIN ; Cheng, Hui-Ching; Yen, Chia-Jui; Hung, Ching-Hsia; Huang, Yu-Ting; Yang, Hsin-Lun; Cheng, Wan-Ting; Tsai, Kun-Ling | International journal of environmental research and public health | 19 | 9 | |
2015 | Efficacy and safety of nintedanib (N) versus sorafenib (S) in Caucasian and Asian patients with advanced hepatocellular carcinoma (HCC): Pooled analysis of two randomized phase II trials. | Meyer, Tim; Palmer, Daniel H.; Chao, Yee; Choi, Caren; Deptala, Andrzej; Fartoux, Laetitia; Feng, Yin-Hsun; Graham, Janet Shirley; Hocke, Julia; Kim, Tae-You; Lin, Deng-Yn; Ma, Yuk Ting; Peck-Radosavljevic, Markus; Ross, Paul J.; Ryoo, Baek-Yeol; Wenz, Arne; Yen, Chia-Jui; Loembe, Arsene-Bienvenu; Cheng, Ann-Lii; 鄭安理 | J. Clin. Oncol. | | | |
2015 | Efficacy and safety of nintedanib (N) versus sorafenib (S) in Caucasian and Asian patients with advanced hepatocellular carcinoma (HCC): Pooled analysis of two randomized phase II trials. | Meyer, Tim; Palmer, Daniel H.; Chao, Yee; Choi, Caren; Deptala, Andrzej; Fartoux, Laetitia; Feng, Yin-Hsun; Graham, Janet Shirley; Hocke, Julia; Kim, Tae-You; Lin, Deng-Yn; Ma, Yuk Ting; Peck-Radosavljevic, Markus; Ross, Paul J.; Ryoo, Baek-Yeol; Wenz, Arne; Yen, Chia-Jui; Loembe, Arsene-Bienvenu; Cheng, Ann-Lii | J. Clin. Oncol. | | | |
2022 | A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors | Chan, Stephen L; Schuler, Martin; Kang, Yoon-Koo; Yen, Chia-Jui; Edeline, Julien; Choo, Su Pin; CHIA-CHI LIN ; Okusaka, Takuji; Weiss, Karl-Heinz; Macarulla, Teresa; Cattan, Stéphane; Blanc, Jean-Frederic; Lee, Kyung-Hun; Maur, Michela; Pant, Shubham; Kudo, Masatoshi; Assenat, Eric; Zhu, Andrew X; Yau, Thomas; Lim, Ho Yeong; Bruix, Jordi; Geier, Andreas; Guillén-Ponce, Carmen; Fasolo, Angelica; Finn, Richard S; Fan, Jia; Vogel, Arndt; Qin, Shukui; Riester, Markus; Katsanou, Vasiliki; Chaudhari, Monica; Kakizume, Tomoyuki; Gu, Yi; Porta, Diana Graus; Myers, Andrea; Delord, Jean-Pierre | Journal of experimental & clinical cancer research : CR | 20 | | |
2023 | The impact of preoperative waiting time in Stage II-III gastric or gastroesophageal junction cancer: A population-based cohort study | Yen, Chih-Chieh; Yang, Yi-Hsin; Ku, Hsiu-Ying; Hu, Huang-Ming; Lo, Su-Shun; Chang, Hung-Chi; Chao, Yee; Chen, Jen-Shi; HSIU-PO WANG ; Wang, Tsang-En; Bai, Li-Yuan; MING-SHIANG WU ; Yen, Chia-Jui; Chen, Li-Tzong; Shan, Yan-Shen | Cancer medicine | 1 | 0 | |
2018 | Organ-specific differential responses to immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma | Lu, Li-Chun; Hsu, Chiun; Shao, Yu-Yun; Chao, Yee; Yen, Chia-Jui; Shih, I.-Lun; Hung, Yi-Ping; Chang, Chun-Jung; Shen, Ying-Chun; Guo, Jhe-Cyuan; Liu, Tsung-hao; Hsu, Chih-Hung; Cheng, Ann-Lii; YI-PING HUNG | Cancer Research | 0 | 1 | |
2022 | Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment | Chen, Ching-Tso; Feng, Yin-Hsun; Yen, Chia-Jui; Chen, San-Chi; Lin, Yun-Tzu; LI-CHUN LU ; CHIH-HUNG HSU ; ANN-LII CHENG ; YU-YUN SHAO | Hepatology international | 14 | 14 | |
2023 | Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer | Su, Yung-Yeh; Chiang, Nai-Jung; Yang, Yi-Hsin; Yen, Chia-Jui; Bai, Li-Yuan; Chiu, Chang-Fang; Chuang, Shih-Chang; SHIH HUNG YANG ; Chou, Wen-Chi; Chen, Jen-Shi; Chiu, Tai-Jan; Chen, Yen-Yang; Chan, De-Chuan; Peng, Cheng-Ming; Chiu, Sz-Chi; Li, Chung-Pin; Shan, Yan-Shen; Chen, Li-Tzong | Cancers | 2 | 0 | |
2023 | Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial | Ren, Zhenggang; Ducreux, Michel; Abou-Alfa, Ghassan K; Merle, Philippe; Fang, Weijia; Edeline, Julien; Li, Zhiwei; Wu, Lihua; Assenat, Eric; Hu, Sheng; Rimassa, Lorenza; Zhang, Tao; Blanc, Jean-Frédéric; Pan, Hongming; Ross, Paul; Yen, Chia-Jui; Tran, Albert; Shao, Guoliang; Bouattour, Mohamed; Chen, Yajin; Meyer, Tim; Hou, Jinlin; Tougeron, David; Bai, Yuxian; Hou, Ming-Mo; Meng, Zhiqiang; Wu, John; Li, Vincent; Chica-Duque, Sandra; ANN-LII CHENG | Liver cancer | 10 | 10 | |